Home Ingredients AstaBead® (Astaxanthin Beadlet)
Hair, Skin & NailsEye HealthAntioxidant

AstaBead® (Astaxanthin Beadlet)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

AstaBead® delivers astaxanthin, a red carotenoid from microalgae, in a microencapsulated beadlet form that its supplier markets for stability and easy handling in tablets, capsules and powders. Small human trials link oral astaxanthin to modest gains in skin moisture and elasticity and to reduced eye fatigue.

Studied Dose Commonly 4 to 12 mg of astaxanthin per day.
Active Compound Astaxanthin, a red carotenoid antioxidant, typically from Haematococcus pluvialis microalgae.

Benefits

Skin health

In a review of nine small oral trials, astaxanthin significantly improved skin moisture and elasticity versus placebo in pooled results, but it did not significantly reduce wrinkle depth. Results varied between studies, especially for elasticity. The trials used astaxanthin capsules, mostly oil-based, rather than the AstaBead beadlet form, so these results reflect astaxanthin in general.

Supported by Trial 1

Blood oxidative stress markers: mild, variable drops in astaxanthin trials

Astaxanthin is a strong antioxidant in laboratory tests. In human trials, pooled data show only mild, variable drops in blood oxidative markers such as malondialdehyde, so this is a mechanism rather than a proven clinical benefit.

Supported by Trial 1

Eye comfort

Two small randomized trials, each funded by the company that supplied its astaxanthin, report modest effects. In children with heavy screen use, 4 mg daily for 12 weeks lowered eye strain and visual fatigue scores versus placebo. In adult screen workers, 9 mg daily for 6 weeks better preserved post-screen visual acuity in those aged 40 and over, but not in younger adults. Neither trial used the AstaBead beadlet.

Supported by Trial 1

Mechanism of action

1

Singlet-oxygen quenching

Astaxanthin's unique structure lets it span cell membranes and quench singlet oxygen and free radicals in laboratory studies.

2

Anti-inflammatory action

By lowering oxidative stress, astaxanthin may dampen inflammatory signaling; in pooled human trials it lowered blood IL-6 in people with type 2 diabetes, but CRP and TNF-alpha did not change significantly.

Clinical trials

1
Astaxanthin and Skin Aging: Meta-Analysis
PubMed

Systematic review and meta-analysis of astaxanthin on human skin aging. (Zhou et al. 2021, Nutrients)

Adults across multiple trials.

Of nine small oral randomized trials reviewed, eight were pooled: astaxanthin significantly improved skin moisture (SMD 0.53) and elasticity (SMD 0.77) versus placebo, but the reduction in wrinkle depth was not statistically significant. Heterogeneity was moderate for moisture and high for elasticity. The trials used Haematococcus pluvialis astaxanthin, mostly as oil-based capsules, and none used the AstaBead beadlet form.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated: adverse effects are uncommon.
High doses may give a slight reddish skin tint (harmless).
Mild digestive upset is occasionally reported.

Important Drug interactions

Anticoagulants or antiplatelet drugs: possible additive effect based on animal and cell studies; ask your doctor.
Human data on interactions with other medications are limited.
Tell your doctor if pregnant or breastfeeding.

More Hair, Skin & Nails Ingredients

Hair, Skin & Nails
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Hair, Skin & Nails
Bovine Collagen
Bovine collagen is hydrolyzed collagen sourced from cow hide, bone, and cartilage. It is o…
Hair, Skin & Nails
Marine Collagen
Marine collagen is hydrolyzed collagen made from fish skin and scales, mainly type I colla…
Hair, Skin & Nails
Astaxanthin
Astaxanthin is a red-orange carotenoid antioxidant. It is naturally produced by the microa…

Explore Other Ingredients

Bone Health
Collagen
Collagen is the main structural protein of skin, bone, cartilage, tendons and ligaments. S…
Hair, Skin & Nails
Hyaluronic Acid
Hyaluronic acid is a naturally occurring substance in the body, primarily found in connect…
Immune Support
Vitamin C
Vitamin C (L-ascorbic acid) is a water-soluble vitamin that humans cannot make, so it must…

Frequently asked questions about AstaBead® (Astaxanthin Beadlet)

What is AstaBead?

AstaBead® delivers astaxanthin, a red carotenoid from microalgae, in a microencapsulated beadlet form that its supplier markets for stability and easy handling in tablets, capsules and powders. Small human trials link oral astaxanthin to modest gains in skin moisture and elasticity and to reduced eye fatigue.

What is AstaBead used for?

AstaBead is researched primarily for Hair, Skin & Nails, Eye Health, and Antioxidant. In a review of nine small oral trials, astaxanthin significantly improved skin moisture and elasticity versus placebo in pooled results, but it did not significantly reduce wrinkle depth.

What is the recommended dosage of AstaBead?

The clinically studied dose is Commonly 4 to 12 mg of astaxanthin per day. Always follow the product label and check with a healthcare provider for personal advice.

Is AstaBead safe, and does it have side effects?

Side effects and cautions reported for AstaBead include: Generally well-tolerated: adverse effects are uncommon. High doses may give a slight reddish skin tint (harmless). It may also interact with some medications. AstaBead is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does AstaBead interact with any medications?

Possible interactions include: Anticoagulants or antiplatelet drugs: possible additive effect based on animal and cell studies; ask your doctor. Human data on interactions with other medications are limited. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for AstaBead?

NutraSmarts rates the evidence for AstaBead as Limited (2 out of 5). It is backed by 1 study summary and 7 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(7 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zhou X, Cao Q, Orfila C, Zhao J, Zhang L. Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing. Nutrients. 2021;13(9):2917..PubMedUsed to support: Systematic review of nine small oral randomized trials, eight of them pooled: astaxanthin improved skin moisture (SMD 0.53) and elasticity (SMD 0.77) versus placebo, with no significant effect on wrinkle depth; heterogeneity was moderate for moisture (I2 52%) and high for elasticity (I2 75%).
  2. Martinez-Perez C, Oliveira AP. Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials. Nutrients. 2025;18(1):4..PubMedUsed to support: Systematic review of nine RCTs in people with or at risk of myopia. Its only astaxanthin trial (4 mg/day for 84 days in 64 children) improved visual fatigue scores and stereopsis versus placebo but not visual acuity, refraction or accommodation; trials overall were small, short and heterogeneous, with no clear effect on myopia progression.
  3. Hecht KA, Marwah M, Wood V, Nishida Y, Bach AE, Gerson J, Hom MM, Schnackenberg J, Raote S, Srivastava S, Negi P, Caston E. Astaxanthin (AstaReal(®)) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial. Adv Ther. 2025;42(4):1811-1833..PubMedUsed to support: RCT in 64 children aged 10 to 14 with at least 4 hours of daily screen time: 4 mg/day astaxanthin (AstaReal soft capsule) for 84 days improved computer vision syndrome questionnaire and visual fatigue scores versus placebo, with no difference in visual acuity or accommodation. Funded by Fuji Chemical Industries, the AstaReal maker, whose group employed several authors.
  4. Sekikawa T, Kizawa Y, Li Y, Miura N. Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study. J Clin Biochem Nutr. 2023;72(1):74-81..PubMedUsed to support: RCT in 60 healthy adults doing regular screen work: 9 mg/day astaxanthin (Haematococcus soft capsule) for 6 weeks better preserved visual acuity after screen work versus placebo in participants aged 40 and over but not in those under 40; functional visual acuity and pupil constriction did not differ. Sponsored by the capsule supplier, BGG Japan.
  5. Ma B, Lu J, Kang T, Zhu M, Xiong K, Wang J. Astaxanthin supplementation mildly reduced oxidative stress and inflammation biomarkers: a systematic review and meta-analysis of randomized controlled trials. Nutr Res. 2022;99:40-50..PubMedUsed to support: Meta-analysis of 12 RCTs (380 participants): astaxanthin lowered blood malondialdehyde versus placebo (SMD -0.95), including in people with type 2 diabetes (SMD -0.64); data on other oxidative markers were limited, and CRP and TNF-alpha did not change significantly.
  6. Wu D, Xu H, Chen J, Zhang L. Effects of Astaxanthin Supplementation on Oxidative Stress. Int J Vitam Nutr Res. 2020;90(1-2):179-194..PubMedUsed to support: Meta-analysis of nine RCTs: versus control, astaxanthin's malondialdehyde-lowering effect was only borderline (p = 0.050), doses under 20 mg/day showed no significant effect, and the authors concluded its antioxidant effect in humans is unclear.
  7. Zhang L, Luo Y, Lei N, Chen S, Lv K, Xiang H, Tang Z, Li B, Zheng X, Li S, Wang X, Li M, Liu H, Zhang B, Wang J, Xu X, Fang C. Astaxanthin suppresses thrombosis by inhibiting both platelet activation and blood coagulation. Br J Pharmacol. 2026;183(11):2890-2912..PubMedUsed to support: Rat, mouse and human cell study: astaxanthin reduced platelet aggregation and suppressed blood coagulation, the basis for a possible additive effect with anticoagulant or antiplatelet drugs; it is not a human drug-interaction study.